Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer

Chest

Volumn 112, Issue 5, 1997, Pages 1332-1337

  Kwong, Yok Lam ^a,b   Chen, Shu Hsia ^a   Kosai, Ken ^a   Finegold, Milton ^a   Woo, Savio L C ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoviral vectors; Cytokine gene; Gene therapy; Liver metastases; Lung cancer; Suicide gene

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; GANCICLOVIR; INTERLEUKIN 2; THYMIDINE KINASE; VIRUS ENZYME;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE THERAPY; HERPES SIMPLEX VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER METASTASIS; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE;

EID: 0030701975     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.5.1332     Document Type: Article

References (24)

1. Coleman MP, Esteve J, Damiecki P, et al. Trends in cancer incidence and mortality. IARC Scientific Publications, No. 121, Lyon, France, 1993; 311-42
2. Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: JB Lippincott, 1993; 673-723
3. Bunn PA, Jr. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions. Semin Oncol 1994; 21(suppl 6):49-59
4. Ihde DC, Pass HI, Glastein EJ. Small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: JB Lippincott, 1993; 723-58
5. Paesmans M, Sculier JP, Libert P, et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients: the European Lung Cancer Working Party. J Clin Oncol 1995; 13:1221-30
6. Anderson WF. Gene therapy for cancer. Human Gene Ther 1994; 5:1-2
7. Whartenby KA, Abboud CN, Marrogi AJ, et al. The biology of cancer gene therapy. Lab Invest 1995; 72:131-45
8. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46:5276-81
9. Freeman SM, Abboud CN, Whartenby KA, et al. The bystander effect: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-83
10. Bi WL, Parysek LM, Warnick R, et al. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Human Gene Ther 1993; 4:725-31
11. Tepper RE, Mulé JJ. Experimental and clinical studies of cytokine gene-modified tumor cells. Human Gene Ther 1994; 5:153-64
12. Nanda NK, Sercarz EE. Induction of anti-self-immunity to cure cancer. Cell 1995; 82:13-17
13. Dalgleish AG. The role of IL-2 in gene therapy. Gene Ther 1994; 1:83-87
14. Chen SH, Shine D, Goodman JC, et al. Gene therapy for brain tumors: regression of experimental glioma by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994; 91:3054-57
15. O'Malley BW, Jr, Chen SH, Schwartz MR, et al. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 1995; 55:1080-85
16. Chen SH, Chen XHL, Wang Y, et al. Combination gene therapy for liver metastases of colon carcinoma. Proc Natl Acad Sci USA 1995; 92:2577-81
17. Takamiya Y, Short MP, Ezzeddine ZD, et al. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 1992; 33:493-503
18. Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256:1550-52
19. Caruso M, Pania Y, Gagandeep S, et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993; 90:7024-28
20. Porgador A, Gansbacher B, Bannerji R, et al. Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells. Int J Cancer 1993; 33:471-77
21. Ohira T, Ohe Y, Heike Y, et al. Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin-2 cD-NAs co-transfected subline. Gene Ther 1994; 1:269-75
22. Chen SH, Kosai KI, Xu B, et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival. Cancer Res 1996; 56:3758-62
23. Mandelboim O, Berke G, Fridkin M, et al. CTL induction by a tumor associated antigen octapeptide derived from a murine lung carcinoma. Nature 1994; 369:67-71
24. Mandelboim O, Vadai E, Fridkin M, et al. Regression of established murine carcinoma metastases following vaccination with tumor-associated antigen peptide. Nature Med 1995; 11:1179-83